Trial Site Detail

 

Drug:
Ripretinib plus Binimetinib
Trial:
Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Withdrawn

 

Princess Margaret Hospital

610 University Ave     
Toronto , ON M5G 2M9
Canada

 

Principal Investigator:
Albiruni Razak, MB MRCPI
Contact:
Activation Status of this Site:
Not yet activated
Notes about this Site:
Princess Margaret Hospital Website:
http://www.uhn.ca/index.asp

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.